These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 28365007)

  • 1. Future remnant liver function as predictive factor for the hypertrophy response after portal vein embolization.
    Cieslak KP; Huisman F; Bais T; Bennink RJ; van Lienden KP; Verheij J; Besselink MG; Busch ORC; van Gulik TM
    Surgery; 2017 Jul; 162(1):37-47. PubMed ID: 28365007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: Liver volume overestimates liver function.
    Olthof PB; Tomassini F; Huespe PE; Truant S; Pruvot FR; Troisi RI; Castro C; Schadde E; Axelsson R; Sparrelid E; Bennink RJ; Adam R; van Gulik TM; de Santibanes E
    Surgery; 2017 Oct; 162(4):775-783. PubMed ID: 28732555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of split completeness on future liver remnant hypertrophy in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma: Complete-ALPPS versus partial-ALPPS.
    Chan ACY; Chok K; Dai JWC; Lo CM
    Surgery; 2017 Feb; 161(2):357-364. PubMed ID: 27596751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of Percutaneous Intrahepatic Split by Microwave Ablation (PISA) After Portal Vein Embolization for Hypertrophy of Future Liver Remnant: The Radiological Stage-1 ALPPS.
    Lunardi A; Cervelli R; Volterrani D; Vitali S; Lombardo C; Lorenzoni G; Crocetti L; Bargellini I; Campani D; Pollina LE; Cioni R; Caramella D; Boggi U
    Cardiovasc Intervent Radiol; 2018 May; 41(5):789-798. PubMed ID: 29359240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases.
    Deshayes E; Piron L; Bouvier A; Lapuyade B; Lermite E; Vervueren L; Laurent C; Pinaquy JB; Chevallier P; Dohan A; Rode A; Sengel C; Guillot C; Quenet F; Guiu B
    BMC Cancer; 2020 Jun; 20(1):574. PubMed ID: 32560632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsuperiority of technetium-99m-galactosyl human serum albumin scintigraphy over conventional volumetry for assessing the future liver remnant in patients undergoing hepatectomy after portal vein embolization.
    Yao S; Taura K; Yoh T; Nishio T; Koyama Y; Ogiso S; Okamoto T; Fukumitsu K; Ishii T; Seo S; Hata K; Masui T; Shimizu H; Ishimori T; Hatano E
    Surgery; 2023 Feb; 173(2):435-441. PubMed ID: 36372575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Greater hypertrophy can be achieved with associating liver partition with portal vein ligation for staged hepatectomy compared to conventional staged hepatectomy, but with a higher price to pay?
    Chia DKA; Yeo Z; Loh SEK; Iyer SG; Bonney GK; Madhavan K; Kow AWC
    Am J Surg; 2018 Jan; 215(1):131-137. PubMed ID: 28859921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion -- an extension of the ALPPS approach.
    Tschuor Ch; Croome KP; Sergeant G; Cano V; Schadde E; Ardiles V; Slankamenac K; Clariá RS; de Santibaňes E; Hernandez-Alejandro R; Clavien PA
    Eur J Surg Oncol; 2013 Nov; 39(11):1230-5. PubMed ID: 23994139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Portal vein embolization: Present and future].
    Piron L; Deshayes E; Escal L; Souche R; Herrero A; Pierredon-Foulongne MA; Assenat E; le Lam N; Quenet F; Guiu B
    Bull Cancer; 2017 May; 104(5):407-416. PubMed ID: 28477870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management.
    Truant S; Scatton O; Dokmak S; Regimbeau JM; Lucidi V; Laurent A; Gauzolino R; Castro Benitez C; Pequignot A; Donckier V; Lim C; Blanleuil ML; Brustia R; Le Treut YP; Soubrane O; Azoulay D; Farges O; Adam R; Pruvot FR;
    Eur J Surg Oncol; 2015 May; 41(5):674-82. PubMed ID: 25630689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of hepatobiliary scintigraphy in assessing ALPPS most suited timing.
    Truant S; Baillet C; Deshorgue AC; El Amrani M; Huglo D; Pruvot FR
    Updates Surg; 2017 Sep; 69(3):411-419. PubMed ID: 28795384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure.
    Leung U; Simpson AL; Araujo RL; Gönen M; McAuliffe C; Miga MI; Parada EP; Allen PJ; D'Angelica MI; Kingham TP; DeMatteo RP; Fong Y; Jarnagin WR
    J Am Coll Surg; 2014 Oct; 219(4):620-30. PubMed ID: 25158914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery.
    Zhang GQ; Zhang ZW; Lau WY; Chen XP
    Int J Surg; 2014; 12(5):437-41. PubMed ID: 24704086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chance and challenge of associating liver partition and portal vein ligation for staged hepatectomy.
    Xiang F; Hu ZM
    Hepatobiliary Pancreat Dis Int; 2019 Jun; 18(3):214-222. PubMed ID: 31056484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring future liver remnant function prior to hepatectomy may guide the indication for portal vein occlusion and avoid posthepatectomy liver failure: a prospective interventional study.
    Chapelle T; Op de Beeck B; Roeyen G; Bracke B; Hartman V; De Greef K; Huyghe I; Van der Zijden T; Morrison S; Francque S; Ysebaert D
    HPB (Oxford); 2017 Feb; 19(2):108-117. PubMed ID: 27956027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and volumetric assessment of liver segments after portal vein embolization: Differences in hypertrophy response.
    Rassam F; Olthof PB; van Lienden KP; Bennink RJ; Besselink MG; Busch OR; van Gulik TM
    Surgery; 2019 Apr; 165(4):686-695. PubMed ID: 30573191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection.
    de Graaf W; van Lienden KP; Dinant S; Roelofs JJ; Busch OR; Gouma DJ; Bennink RJ; van Gulik TM
    J Gastrointest Surg; 2010 Feb; 14(2):369-78. PubMed ID: 19937195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) - new opportunity in two-stage liver resection in patients with colorectal cancer metastases].
    Skipenko OG; Chardarov NK; Bagmet NN; Bedzhanian AL; Polishchuk LO; Shatverian GA
    Khirurgiia (Mosk); 2014; (9):23-9. PubMed ID: 25327741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy does not affect future liver remnant growth and outcomes of associating liver partition and portal vein ligation for staged hepatectomy.
    Hasselgren K; Malagò M; Vyas S; Campos RR; Brusadin R; Linecker M; Petrowsky H; Clavien PA; Machado MA; Hernandez-Alejandro R; Wanis K; Valter L; Sandström P; Björnsson B
    Surgery; 2017 May; 161(5):1255-1265. PubMed ID: 28081953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting liver failure after extended right hepatectomy following right portal vein embolization with gadoxetic acid-enhanced MRI.
    Theilig D; Steffen I; Malinowski M; Stockmann M; Seehofer D; Pratschke J; Hamm B; Denecke T; Geisel D
    Eur Radiol; 2019 Nov; 29(11):5861-5872. PubMed ID: 30899977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.